Health Care/Hospital
Co-PSMA abstract accepted for oral presentation at EAU Annual Congress 2026
SYDNEY, Dec. 24, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the acceptance of an ...
2025-12-24 22:02
1148
Mabwell Receives IND Clearance for Novel Anti-ST2 Monoclonal Antibody 9MW1911 to Initiate Phase IIa Study
SHANGHAI, Dec. 24, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that it has received IND clearance from the U.S. Food and Drug Administration (FDA) for its self-developed anti-ST2 monoclonal antibody (R&...
2025-12-24 22:00
1387
HKSH Medical Group Signed Memorandum of Understanding with Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen To Advance Precision Proton Therapy, Furthering the Healthy China Initiative
HONG KONG, Dec. 24, 2025 /PRNewswire/ -- In alignment with the national framework for the advancement of proton therapy, facilitated by the National Cancer Center, HKSH Medical Group ("HKSH") and Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen ("Shenzhen Cancer Hospital") signed a me...
2025-12-24 15:49
1443
Hakka Medicine Goes Global: Jiaying Pharmaceutical Launches the Global Promotion Plan for Hakka Medicine in Hong Kong
HONG KONG, Dec. 24, 2025 /PRNewswire/ -- Recently, Guangdong Jiaying Pharmaceutical Co., Ltd. held the "First Hakka Medicine Historical and Cultural Symposium" and the "Jiaying Hakka Medicine - Double-ingredient Throat Wind Relief Powder Product Promotion Conference" inHong Kong SAR. Centered on ...
2025-12-24 10:00
1292
Nona Biosciences Expands Integrated Discovery-to-Clinical Capabilities Through Strategic Platform Growth
CAMBRIDGE, Mass., Dec. 23, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, today announced the expansion of its integrated discovery and development framework to support early clinical development an...
2025-12-24 09:20
1410
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on Gastric Cancer.
SEONGNAM, South Korea, Dec. 23, 2025 /PRNewswire/ -- SN Bioscience Inc. (CEO Young Hwan PARK) announced that the FDA had granted Orphan Drug Designation (ODD) onDecember 10 for gastric cancer (including gastroesophageal junction cancer) to SNB-101 (API: SN-38) which is a polymer nanoparticle drug...
2025-12-24 07:37
1288
NAVER D2SF-Backed Startups Participate in "CES 2026"
* Five teams won CES Innovation Awards, including one Best of Innovation Award and three double Innovation Award winners * Proving technological capabilities on the global stage across diverse sectors, including mobility, vertical AI, and healthcare * Over 80% of portfolio companies targetin...
2025-12-24 00:00
2022
Puainta Smashes Black Friday Records and Marks Successful Entry into UK Market
LOS ANGELES, Dec. 22, 2025 /PRNewswire/ -- Puainta, a rapidly growing innovator in pet healthcare and wellness, today announced significant milestones following the 2025 Black Friday sales event. The brand reported an unprecedented surge in global sales, a successful strategic expansion into the ...
2025-12-24 00:00
1625
Bridging the "Last Mile" of Medical Innovation: ICMIS 2025 Successfully Concludes with Capital and Industry Collaborating to Accelerate Commercialization
HONG KONG, Dec. 23, 2025 /PRNewswire/ -- In the current global MedTech landscape, technological breakthroughs are only the starting point. The real measure of scientific research is whether laboratory discoveries can be translated into safe, effective, and widely used clinical products. Yet the ...
2025-12-23 23:03
2507
Senhwa Biosciences Highlights AI-Validated Oncology Platform and Strategic Clinical Collaborations Targeting Next-Generation Immuno-Oncology products at Its 2025 Annual Investor Conference
TAIPEI and SAN DIEGO, Dec. 23, 2025 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage companies focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today outlined continued progress across its AI-enabled drug developm...
2025-12-23 20:00
2273
Fapon Biopharma Publishes Pioneering Research in Cell Reports Medicine on FP008, an anti-PD 1 X IL-10M Fusion Protein for Cancer Immunotherapy
DONGGUAN, China, Dec. 23, 2025 /PRNewswire/ -- Fapon Biopharma, a biotech in developing therapeutic biologics including cytokine-antibody fusion proteins and T-cell engagers, announced the publication of pioneering research on FP008, a novel fusion protein inCell Reports Medicine. The peer-review...
2025-12-23 13:03
2362
HICC Pet × Marina One - Mental Wellness Month: Healing Moments with Dogs at HICC Pet Showroom
SINGAPORE, Dec. 23, 2025 /PRNewswire/ -- This October, Marina One hosted a meaningful Mental Wellness Month event in the heart ofSingapore's CBD. HICC Pet was pleased to participate as one of the contributing partners, offering pet-supported interactions to enhance the community wellness initiat...
2025-12-23 12:09
1940
MindHYVE.ai™ and KPSIAJ Sign Strategic MOU to Advance AI-Driven Innovation in Education and Healthcare Across Karachi
KARACHI, Pakistan, Dec. 23, 2025 /PRNewswire/ -- MindHYVE.ai, Inc., and Khoja (Pirhai) Shia Isna Asheri Jamaat (KPSIAJ) announced the signing of a landmark Memorandum of Understanding (MOU) establishing a strategic collaboration to introduce responsible, community-centered AI innovation across KP...
2025-12-23 07:30
1821
Temu Signs Australian Equipment Safety Pledge to Enhance Consumer Protection
SYDNEY, Dec. 23, 2025 /PRNewswire/ -- Temu has joined the Australian Communications and Media Authority (ACMA)'s Equipment Safety Pledge, a new voluntary initiative aimed at strengthening consumer protections and reduce the availability of unsafe or illegal communications devices sold online. Tem...
2025-12-23 07:00
1393
TraceLink Wins 2025 Merit Award -- Recognized for Healthcare Innovation for the Third Consecutive Year
TraceLink has been named a winner of the 2025 Merit Awards for Healthcare Innovation, marking its third consecutive year of recognition. The award honors TraceLink's continued leadership in transforming the life sciences and healthcare supply chain through OPUS—its industrial no-code platform tha...
2025-12-22 23:00
1932
MCB Group Unveils Daily Sports Nutrition Innovations at SupplySide Global 2025, Spotlighting Creatine, MCT, and Plant-Based Protein
TAIPEI, Dec. 22, 2025 /PRNewswire/ -- MCB Group, a Taiwan-based global
manufacturer ofpremium nutritional powder ingredients
2025-12-22 22:00
2454
Kazia Therapeutics Regains Full Nasdaq Listing Compliance
Restoration of Nasdaq compliance follows $50 million institutional financing and reinforces balance-sheet strength SYDNEY, Dec. 22, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") (NASDAQ: KZIA), a clinical-stage oncology company focused on developing innovative therap...
2025-12-22 21:00
3011
AI Platform to Combat Muscle Loss and Preserve Metabolic Vitality for GLP-1 Users
Livelively USA combines AI insights with Eastern wellness principles to support healthier long-term weight management behaviors. NEW YORK, Dec. 22, 2025 /PRNewswire/ -- Weight-loss medications are reshaping global healthcare, with the anti-obesity drug market projected to approach$100 billion by...
2025-12-22 21:00
1249
Yii Partners with Japan's ANDS Corporation: Building Skin Resilience through Pharmaceutical-Grade Science
HONG KONG, Dec. 22, 2025 /PRNewswire/ -- Japanese skincare brand Yii is collaborating with ANDS Corporation (hereinafter "ANDS"), an affiliate of Rohto Pharmaceutical Co., Ltd., to explore the niche skincare market with pharmaceutical-grade scientific excellence. The collaboration combines over 6...
2025-12-22 17:51
1671
Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH® CTC enumeration to guide treatment decisions in a specific metastatic breast cancer subtype
The secondary analysis of the PACE trial highlights the value of counting Circulating Tumor Cells (CTCs) in the blood to help guide treatment escalation or de-escalation in patients with hormone receptor-positive (HR+), HER2-negative (HER2-) metastatic breast cancer whose disease progressed after...
2025-12-22 16:00
2062
Week's Top Stories
Most Reposted
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 278 media titles]
2025-12-26 12:55ACEN completes transition to 100% renewable energy
[Picked up by 273 media titles]
2025-12-29 18:53Vietnam's Newest EDM Destination, APLUS SAIGON, Debuts With Star-Studded Soft Opening Weekends Featuring Dombresky and Argy
[Picked up by 263 media titles]
2025-12-30 20:12
CYFIRMA's 2025 Impact Recap Showcases DeCYFIR, Preemptive External Threat Landscape Management Platform, Delivering Measurable Global Defense Against Emerging Threats
[Picked up by 262 media titles]
2025-12-29 09:00
ChinaAMC launches Depository Receipts of two Chinese flagship ETFs in Thai exchange
[Picked up by 259 media titles]
2025-12-29 14:27